Seminars in Hematology
Volume 43, Issue 1 , Pages 62-69 , January 2006

CD4+CD25+ Regulatory T Cells and Graft-Versus-Host Disease

  • Petra Hoffmann
  • ,
  • Matthias Edinger

      Affiliations

    • Corresponding Author InformationAddress correspondence to Matthias Edinger, MD, Department of Hematology and Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.

References 

  1. Ho VT , Soiffer RJ . The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation . Blood . 2001;98:3192–3204
  2. Sprent J , Kishimoto H . The thymus and negative selection . Immunol Rev . 2002;185:126–135
  3. Wucherpfennig KW , Zhang J , Witek C , Matsui M , Modabber Y , Ota K , et al.   Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide . J Immunol . 1994;152:5581–5592
  4. Sakaguchi S . Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses . Annu Rev Immunol . 2004;22:531–562
  5. Sakaguchi S , Sakaguchi N , Asano M , Itoh M , Toda M . Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases . J Immunol . 1995;155:1151–1164
  6. Belkaid Y , Rouse BT . Natural regulatory T cells in infectious disease . Nat Immunol . 2005;6:353–360
  7. Terabe M , Berzofsky JA . Immunoregulatory T cells in tumor immunity . Curr Opin Immunol . 2004;16:157–162
  8. Waldmann H , Graca L , Cobbold S , Adams E , Tone M , Tone Y . Regulatory T cells and organ transplantation . Semin Immunol . 2004;16:119–126
  9. Huang CT , Workman CJ , Flies D , Pan X , Marson AL , Zhou G , et al.   Role of LAG-3 in regulatory T cells . Immunity . 2004;21:503–513
  10. Bruder D , Probst-Kepper M , Westendorf AM , Geffers R , Beissert S , Loser K , et al.   Neuropilin-1 (A surface marker of regulatory T cells) . Eur J Immunol . 2004;34:623–630
  11. Su L , Creusot RJ , Gallo EM , Chan SM , Utz PJ , Fathman CG , et al.   Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene . J Immunol . 2004;173:4994–5001
  12. Bensinger SJ , Walsh PT , Zhang J , Carroll M , Parsons R , Rathmell JC , et al.   Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells . J Immunol . 2004;172:5287–5296
  13. Malek TR , Bayer AL . Tolerance, not immunity, crucially depends on IL-2 . Nat Rev Immunol . 2004;4:665–674
  14. Annacker O , Burlen-Defranoux O , Pimenta-Araujo R , Cumano A , Bandeira A . Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment . J Immunol . 2000;164:3573–3580
  15. Fisson S , Darrasse-Jeze G , Litvinova E , Septier F , Klatzmann D , Liblau R , et al.   Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state . J Exp Med . 2003;198:737–746
  16. Klein L , Khazaie K , von Boehmer H . In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro . Proc Natl Acad Sci U S A . 2003;100:8886–8891
  17. Shevach EM . CD4+ CD25+ suppressor T cells (More questions than answers) . Nat Rev Immunol . 2002;2:389–400
  18. Nakamura K , Kitani A , Strober W . Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta . J Exp Med . 2001;194:629–644
  19. Birebent B , Lorho R , Lechartier H , de Guibert S , Alizadeh M , Vu N , et al.   Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression . Eur J Immunol . 2004;34:3485–3496
  20. Tang Q , Boden EK , Henriksen KJ , Bour-Jordan H , Bi M , Bluestone JA . Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function . Eur J Immunol . 2004;34:2996–3005
  21. Chen ML , Pittet MJ , Gorelik L , Flavell RA , Weissleder R , von Boehmer H , et al.   Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo . Proc Natl Acad Sci U S A . 2005;102:419–424
  22. Fontenot JD , Rudensky AY . A well adapted regulatory contrivance (Regulatory T cell development and the forkhead family transcription factor Foxp3) . Nat Immunol . 2005;6:331–337
  23. Cederbom L , Hall H , Ivars F . CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells . Eur J Immunol . 2000;30:1538–1543
  24. Misra N , Bayry J , Lacroix-Desmazes S , Kazatchkine MD , Kaveri SV . Cutting edge (Human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells) . J Immunol . 2004;172:4676–4680
  25. Fallarino F , Grohmann U , Hwang KW , Orabona C , Vacca C , Bianchi R , et al.   Modulation of tryptophan catabolism by regulatory T cells . Nat Immunol . 2003;4:1206–1212
  26. Brunkow ME , Jeffery EW , Hjerrild KA , Paeper B , Clark LB , Yasayko SA , et al.   Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse . Nat Genet . 2001;27:68–73
  27. Fontenot JD , Gavin MA , Rudensky AY . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells . Nat Immunol . 2003;4:330–336
  28. Khattri R , Cox T , Yasayko SA , Ramsdell F . An essential role for Scurfin in CD4+CD25+ T regulatory cells . Nat Immunol . 2003;4:337–342
  29. Hori S , Nomura T , Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3 . Science . 2003;299:1057–1061
  30. Annunziato F , Cosmi L , Liotta F , Lazzeri E , Manetti R , Vanini V , et al.   Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes . J Exp Med . 2002;196:379–387
  31. Papiernik M , de Moraes ML , Pontoux C , Vasseur F , Penit C . Regulatory CD4 T cells (Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency) . Int Immunol . 1998;10:371–378
  32. Sakaguchi S . Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self . Nat Immunol . 2005;6:345–352
  33. Roncador G , Brown PJ , Maestre L , Hue S , Martinez-Torrecuadrada JL , Ling KL , et al.   Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level . Eur J Immunol . 2005;35:1681–1691
  34. Baecher-Allan C , Viglietta V , Hafler DA . Human CD4+CD25+ regulatory T cells . Semin Immunol . 2004;16:89–98
  35. Fontenot JD , Rasmussen JP , Williams LM , Dooley JL , Farr AG , Rudensky AY . Regulatory T cell lineage specification by the forkhead transcription factor foxp3 . Immunity . 2005;22:329–341
  36. Pop SM , Wong CP , Culton DA , Clarke SH , Tisch R . Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes . J Exp Med . 2005;201:1333–1346
  37. Bensinger SJ , Bandeira A , Jordan MS , Caton AJ , Laufer TM . Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells . J Exp Med . 2001;194:427–438
  38. Jordan MS , Boesteanu A , Reed AJ , Petrone AL , Holenbeck AE , Lerman MA , et al.   Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide . Nat Immunol . 2001;2:301–306
  39. van Santen HM , Benoist C , Mathis D . Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells . J Exp Med . 2004;200:1221–1230
  40. Bettelli E , Dastrange M , Oukka M . Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells . Proc Natl Acad Sci U S A . 2005;102:5138–5143
  41. Hoffmann P , Ermann J , Edinger M , Fathman CG , Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation . J Exp Med . 2002;196:389–399
  42. Taylor PA , Noelle RJ , Blazar BR . CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade . J Exp Med . 2001;193:1311–1318
  43. Jones SC , Murphy GF , Korngold R . Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4(+)25(+) T cells to allow an effective graft-versus-leukemia response . Biol Blood Marrow Transplant . 2003;9:243–256
  44. Edinger M , Hoffmann P , Ermann J , Drago K , Fathman CG , Strober S , et al.   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation . Nat Med . 2003;9:1144–1150
  45. Hanash AM , Levy RB . Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation . Blood . 2005;105:1828–1836
  46. Joffre O , Gorsse N , Romagnoli P , Hudrisier D , Van Meerwijk JP . Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes . Blood . 2004;103:4216–4221
  47. Trenado A , Charlotte F , Fisson S , Yagello M , Klatzmann D , Salomon BL , et al.   Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia . J Clin Invest . 2003;112:1688–1696
  48. Cohen JL , Trenado A , Vasey D , Klatzmann D , Salomon BL . CD4(+)CD25(+) immunoregulatory T Cells (New therapeutics for graft-versus-host disease) . J Exp Med . 2002;196:401–406
  49. Taylor PA , Lees CJ , Blazar BR . The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality . Blood . 2002;99:3493–3499
  50. Xia G , Kovochich M , Truitt RL , Johnson BD . Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease . Biol Blood Marrow Transplant . 2004;10:748–760
  51. Kubsch S , Graulich E , Knop J , Steinbrink K . Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells (association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1) . Eur J Immunol . 2003;33:1988–1997
  52. Teshima T , Ordemann R , Reddy P , Gagin S , Liu C , Cooke KR , et al.   Acute graft-versus-host disease does not require alloantigen expression on host epithelium . Nat Med . 2002;8:575–581
  53. Shlomchik WD , Couzens MS , Tang CB , McNiff J , Robert ME , Liu J , et al.   Prevention of graft versus host disease by inactivation of host antigen-presenting cells . Science . 1999;285:412–415
  54. Murai M , Yoneyama H , Ezaki T , Suematsu M , Terashima Y , Harada A , et al.   Peyer’s patch is the essential site in initiating murine acute and lethal graft-versus-host reaction . Nat Immunol . 2003;4:154–160
  55. Li B , New JY , Tay YK , Goh E , Yap EH , Chan SH , et al.   Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at L-selectin and alpha4-integrin prior to infusion . Scand J Immunol . 2004;59:464–468
  56. Anderson BE , McNiff J , Yan J , Doyle H , Mamula M , Shlomchik MJ , et al.   Memory CD4+ T cells do not induce graft-versus-host disease . J Clin Invest . 2003;112:101–108
  57. Chen BJ , Cui X , Sempowski GD , Liu C , Chao NJ . Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease . Blood . 2004;103:1534–1541
  58. Ermann J , Hoffmann P , Edinger M , Dutt S , Blankenberg FG , Higgins JP , et al.   Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD . Blood . 2005;105:2220–2226
  59. Szanya V , Ermann J , Taylor C , Holness C , Fathman CG . The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 . J Immunol . 2002;169:2461–2465
  60. Taylor PA , Panoskaltsis-Mortari A , Swedin JM , Lucas PJ , Gress RE , Levine BL , et al.   L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection . Blood . 2004;104:3804–3812
  61. Thornton AM , Shevach EM . Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific . J Immunol . 2000;164:183–190
  62. Sarween N , Chodos A , Raykundalia C , Khan M , Abbas AK , Walker LS . CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion . J Immunol . 2004;173:2942–2951
  63. Huehn J , Siegmund K , Lehmann JC , Siewert C , Haubold U , Feuerer M , et al.   Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells . J Exp Med . 2004;199:303–313
  64. Iellem A , Mariani M , Lang R , Recalde H , Panina-Bordignon P , Sinigaglia F , et al.   Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells . J Exp Med . 2001;194:847–853
  65. Sebastiani S , Allavena P , Albanesi C , Nasorri F , Bianchi G , Traidl C , et al.   Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity . J Immunol . 2001;166:996–1002
  66. Kolb HJ , Mittermuller J , Clemm C , Holler E , Ledderose G , Brehm G , et al.   Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients . Blood . 1990;76:2462–2465
  67. Raiola AM , Van Lint MT , Valbonesi M , Lamparelli T , Gualandi F , Occhini D , et al.   Factors predicting response and graft-versus-host disease after donor lymphocyte infusions (A study on 593 infusions) . Bone Marrow Transplant . 2003;31:687–693
  68. Truitt RL , Johnson BD . Principles of graft-vs.-leukemia reactivity . Biol Blood Marrow Transplant . 1995;1:61–68
  69. Sprent J , Schaefer M , Lo D , Korngold R . Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences . J Exp Med . 1986;163:998–1011
  70. Ferrara JL . Pathogenesis of acute graft-versus-host disease (Cytokines and cellular effectors) . J Hematother Stem Cell Res . 2000;9:299–306
  71. Stanzani M , Martins SL , Saliba RM , St John LS , Bryan S , Couriel D , et al.   CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans . Blood . 2004;103:1140–1146
  72. Sanchez J , Casano J , Alvarez MA , Roman-Gomez J , Martin C , Martinez F , et al.   Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation . Br J Haematol . 2004;126:697–703
  73. Clark FJ , Gregg R , Piper K , Dunnion D , Freeman L , Griffiths M , et al.   Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells . Blood . 2004;103:2410–2416
  74. Miura Y , Thoburn CJ , Bright EC , Phelps ML , Shin T , Matsui EC , et al.   Association of Foxp3 regulatory gene expression with graft-versus-host disease . Blood . 2004;104:2187–2193
  75. Martin PJ , Pei J , Gooley T , Anasetti C , Appelbaum FR , Deeg J , et al.   Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation . Biol Blood Marrow Transplant . 2004;10:552–560
  76. Godfrey WR , Ge YG , Spoden DJ , Levine BL , June CH , Blazar BR , et al.   In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures . Blood . 2004;104:453–461
  77. Hoffmann P , Eder R , Kunz-Schughart LA , Andreesen R , Edinger M . Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells . Blood . 2004;104:895–903
  78. Jiang S , Camara N , Lombardi G , Lechler RI . Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo . Blood . 2003;102:2180–2186

PII: S0037-1963(05)00172-1

doi: 10.1053/j.seminhematol.2005.09.006

Seminars in Hematology
Volume 43, Issue 1 , Pages 62-69 , January 2006